These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 4948095)
61. [Hansen L: action of thalidomide on a severe outburst]. Duperrat B; Puissant A; Goudie ; David V; Saurat JM Bull Soc Fr Dermatol Syphiligr; 1971; 78(3):291-2. PubMed ID: 5134979 [No Abstract] [Full Text] [Related]
62. Use of thalidomide in leprosy. Crawford CL Adverse Drug React Toxicol Rev; 1994; 13(4):177-92. PubMed ID: 7734638 [No Abstract] [Full Text] [Related]
63. [Therapy of lepromatous erythema nodosum using chloramphenicol. Comparison with thalidomide. Statistical study from the Marchoux Institute]. Saint-André P; Ferracci C; Baquillon G; Ridel PR; Boucher P Acta Leprol; 1981; (84):57-62. PubMed ID: 6797223 [No Abstract] [Full Text] [Related]
64. Supplies of thalidomide for use in leprosy. Neelamkavil P Lepr Rev; 1986 Sep; 57(3):273. PubMed ID: 3784762 [No Abstract] [Full Text] [Related]
65. Thalidomide. A surprising recovery. Stirling D; Sherman M; Strauss S J Am Pharm Assoc (Wash); 1997; NS37(3):306-13. PubMed ID: 9170807 [TBL] [Abstract][Full Text] [Related]
66. [Action of 2 new products, thalidomide and B. 663 on reactive forms of Hansen's disease]. Languillon J Med Trop (Mars); 1969; 29(4):497-503. PubMed ID: 5403099 [No Abstract] [Full Text] [Related]
67. The return of thalidomide: new uses and renewed concerns--reply. Lockwood D; Bryceson A Lepr Rev; 2003 Sep; 74(3):290-4. PubMed ID: 14577479 [No Abstract] [Full Text] [Related]
69. Management of reactions in leprosy. Ramu G J Indian Med Assoc; 1973 Nov; 61(9):403-6. PubMed ID: 4799712 [No Abstract] [Full Text] [Related]
70. Thalidomide: new indication. For elderly myeloma patients: some improvement in first-line treatment. Prescrire Int; 2009 Apr; 18(100):49-52. PubMed ID: 19585712 [TBL] [Abstract][Full Text] [Related]
71. [Limitations, within narrow indications, in the administration of thalidomide]. Ned Tijdschr Geneeskd; 1983 Jun; 127(23):1010. PubMed ID: 6877398 [No Abstract] [Full Text] [Related]
72. [Thalidomide neuropathy in the late stage. A clinical documentation]. Gibbels E; Scheid W; Wieck HH; Kinzel W Fortschr Neurol Psychiatr Grenzgeb; 1973 Jul; 41(7):378-417. PubMed ID: 4490251 [No Abstract] [Full Text] [Related]
73. [Incorporation of thalidomide to the therapeutic arsenal of Hansen's disease (award of the Spanish Academy of Dermatology 1968)]. Sheskin J Actas Dermosifiliogr; 1969; 60(3):57-72. PubMed ID: 5800285 [No Abstract] [Full Text] [Related]
75. Thalidomide in dermatology and leprosy. Lancet; 1985 Jul; 2(8446):80-1. PubMed ID: 2861530 [No Abstract] [Full Text] [Related]
76. Treatment of leprosy in the United States. Levis WR Bull N Y Acad Med; 1984 Sep; 60(7):696-711. PubMed ID: 6386081 [No Abstract] [Full Text] [Related]